{"id":"W4360610525","doi":"10.1136/rmdopen-2022-002718","title":"Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension","year":2023,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Pfizer (Canada); Ottawa Hospital; Toronto Western Hospital; Women's College Hospital; University of Toronto","funders":"Samsung; Genentech; Celltrion; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Kiniksa Pharmaceuticals; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tofacitinib; Internal medicine; Placebo; Discontinuation; Psoriatic arthritis; Rheumatology; Psoriasis Area and Severity Index; Psoriasis; Janus kinase inhibitor; Adalimumab; Post-hoc analysis; Adverse effect; Dactylitis; Arthritis; Physical therapy; Enthesitis; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003434169,0.0001398109,0.001038045,0.000169098,0.00007587211,0.0000218448,0.00007809645,0.00003129819,0.00004195423],"category_scores_gemma":[0.0001205733,0.00007123951,0.00005580032,0.0007371241,0.000141444,0.00006467179,0.00005729607,0.00004551657,4.85696e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001028694,"about_ca_system_score_gemma":0.00002350557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002726356,"about_ca_topic_score_gemma":0.0007253164,"domain_scores_codex":[0.9988425,0.000142197,0.0003613924,0.0002596585,0.0002521999,0.000142015],"domain_scores_gemma":[0.9990568,0.0003732267,0.0001974987,0.0002122495,0.0001106119,0.00004962386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008547815,0.000630471,0.9463958,0.00004357519,0.001271212,0.00009309985,0.002604674,0.000001198428,0.00002598571,0.00000392863,0.000002574948,0.04037974],"study_design_scores_gemma":[0.02955379,0.004840485,0.961537,0.0004422456,0.001538624,0.000006193177,0.00191333,0.00004406471,0.00004343052,0.000001812165,0.000002579075,0.00007643839],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976545,0.0005995937,0.000001349928,0.0001111631,0.000007284143,0.001240489,0.0003185307,0.00000709797,0.00005998375],"genre_scores_gemma":[0.9982482,0.001376705,0.00002695198,0.00002657381,0.000004332625,0.00003136809,0.0002510132,0.000007632932,0.00002725668],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0403033,"threshold_uncertainty_score":0.2905063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05104802132091156,"score_gpt":0.3191608334275893,"score_spread":0.2681128121066777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}